Publisher
Springer International Publishing
Reference70 articles.
1. Abara WE, Collier MG, Moorman A et al (2019) Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses – United States, 2010–2017. MMWR:Morb Mortal Wkly Rep 68:61–66
2. Ahn J, Cohen SM (2008) Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 14:1603–1608
3. Álvarez-López P, Riveiro-Barciela M, Oleas-Vega D et al (2020) Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients. Medicine 99:e19407. https://doi.org/10.1097/MD.0000000000019407
4. American Society for Transplant Physicians; American Thoracic Society; European Respiratory Society; International Society for Heart and Lung Transplantation (1998) International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 158:335–339
5. Aslam S, Grossi P, Schlendorf KH et al (2020) Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: an ISHLT expert consensus statement. J Heart Lung Transplant 39:418–432